D-0622-2017 Class II Terminated

Recalled by Mylan Institutional, Inc. (D.B.A. UDL Laboratories) — Rockford, IL

FDA drug recall D-0622-2017 was initiated by Mylan Institutional, Inc. (D.B.A. UDL Laboratories) on Mar 21, 2017 and is designated Class II. Reason for recall: Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms. The recall status is terminated (terminated Mar 15, 2019). Affected quantity: 1,527 cartons.

Recall details

Product Type
Drugs
Report Date
Apr 5, 2017
Initiation Date
Mar 21, 2017
Termination Date
Mar 15, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,527 cartons

Product description

Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.., NDC 51079-208-20

Reason for recall

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Distribution pattern

Nationwide in the USA

Code information

Lot #: 3084288, Exp. 07/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0622-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0622-2017. Report a data issue: hello@regdatalab.com.